Stocks and InvestingStocks and Investing
Thu, December 12, 2019
Wed, December 11, 2019
Tue, December 10, 2019
Mon, December 9, 2019
Fri, December 6, 2019
Thu, December 5, 2019
Wed, December 4, 2019
Tue, December 3, 2019

Matthew Luchini Downgraded (BOLD) to Hold and Increased Target to $60 on, Dec 3rd, 2019


Published on 2024-10-26 18:45:45 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Downgraded "Boundless Bio, Inc." (BOLD) to Hold and Increased Target from $47 to $60 on, Dec 3rd, 2019.

Matthew has made no other calls on BOLD in the last 4 months.



There is 1 other peer that has a rating on BOLD. Out of the 1 peers that are also analyzing BOLD, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $40 on, Tuesday, November 19th, 2019